Related Experiment Video
Updated: May 5, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Osteomyelitis caused by Aspergillus species: a review of 310 reported cases
E Gabrielli1, A W Fothergill, L Brescini
1Clinica Malattie Infettive, Università Politecnica delle Marche, Ancona, Italy.
Abstract:
Aspergillus osteomyelitis is a rare infection. We reviewed 310 individual cases reported in the literature from 1936 to 2013. The median age of patients was 43 years (range, 0-86 years), and 59% were males. Comorbidities associated with this infection included chronic granulomatous disease (19%), haematological malignancies (11%), transplantation (11%), diabetes (6%), pulmonary disease (4%), steroid therapy (4%), and human immunodeficiency virus infection (4%). Sites of infection included the spine (49%), base of the skull, paranasal sinuses and jaw (18%), ribs (9%), long bones (9%), sternum (5%), and chest wall (4%). The most common infecting species were Aspergillus fumigatus (55%), Aspergillus flavus (12%), and Aspergillus nidulans (7%). Sixty-two per cent of the individual cases were treated with a combination of an antifungal regimen and surgery. Amphotericin B was the antifungal drug most commonly used, followed by itraconazole and voriconazole. Several combination or sequential therapies were also used experimentally. The overall crude mortality rate was 25%.
Insights
Aspergillus osteomyelitis is a rare fungal bone infection. This review of 310 cases highlights spine involvement and common use of combination antifungal and surgical treatments, with a 25% mortality rate.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Orthopedic Surgery
Background:
- Aspergillus osteomyelitis is an uncommon but serious invasive fungal infection.
- Characterized by significant morbidity and mortality, it often affects immunocompromised individuals.
Purpose of the Study:
- To comprehensively review and analyze reported cases of Aspergillus osteomyelitis.
- To identify epidemiological features, common sites of infection, causative species, treatment modalities, and outcomes.
Main Methods:
- Systematic literature review of 310 individual cases of Aspergillus osteomyelitis published between 1936 and 2013.
- Data extraction included patient demographics, comorbidities, infection sites, fungal species, treatments, and mortality.
Main Results:
- The median patient age was 43 years, with a male predominance (59%).
- Common comorbidities included chronic granulomatous disease (19%) and hematological malignancies (11%). The spine was the most frequent site of infection (49%).
- Aspergillus fumigatus was the most common species (55%). Treatment typically involved combined antifungal therapy (Amphotericin B most common) and surgery (62%). The crude mortality rate was 25%.
Conclusions:
- Aspergillus osteomyelitis predominantly affects immunocompromised patients, with the spine being the most common site.
- Combined antifungal and surgical treatment is the standard approach, though mortality remains high.
- Further research into optimal therapeutic strategies is warranted to improve patient outcomes.
Related Concept Videos
Fungal Phylum Ascomycota
Endocarditis III: Medical Management
Endocarditis I: Introduction
Brain Abscess l: Introduction

